Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
Clinical trial NCT00805675 · COMPLETED
Trial details
- NCT number
- NCT00805675
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-12-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.